天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2010年
3期
192-194
,共3页
米淑玲%张军%尹利荣%马鸿达%赵秀兰%王宇全
米淑玲%張軍%尹利榮%馬鴻達%趙秀蘭%王宇全
미숙령%장군%윤리영%마홍체%조수란%왕우전
微管相关蛋白质类%基质金属蛋白酶9%子宫内膜异位症%子宫内膜%细胞凋亡%细胞外基质
微管相關蛋白質類%基質金屬蛋白酶9%子宮內膜異位癥%子宮內膜%細胞凋亡%細胞外基質
미관상관단백질류%기질금속단백매9%자궁내막이위증%자궁내막%세포조망%세포외기질
microtubule-associated proteins%matrix metalloproteinase 9%endometriosis%endometrium%apoptosis extracellular matrix
目的:检测子宫内膜异位症(EMs)患者在位内膜中survivin与MMP-9的表达情况并分析两者表达的相关性.方法:收集80例子宫内膜异位症患者子宫内膜标本为EMs在位内膜组(EMs组),其中临床分期Ⅰ期4例、Ⅱ期25例、Ⅲ期44例与Ⅳ期7例;增殖期47例,分泌期33例.以20例同期手术的单纯子宫肌瘤患者子宫内膜作为对照组,其中增殖期内膜7例,分泌期13例.采用免疫组化二步法检测2组标本中survivin与MMP-9的表达;并应用IPP专业图像分析系统进行定量分析.结果:survivin与MMP-9均在子宫内膜胞浆中表达.在EMs组中增殖期survivin和MMP-9及分泌期survivin表达均高于对照组(P<0.01);其中,survivin表达与细胞周期无关,呈持续性高表达.EMs组不同临床分期间survivin表达,Ⅱ期明显高于Ⅲ期,其余各分期间表达差别无统计学意义(均P>0.05);而MMP-9在各AFS分期中表达差别均无统计学意义(均P>0.05).Pearson相关性分析表明survivin与MMP-9在子宫内膜异位症在位内膜中表达呈正相关(r=0.262,t=2.860,P<0.05).结论:survivin与MMP-9在子宫内膜异位症形成及进展过程中均起关键的作用.
目的:檢測子宮內膜異位癥(EMs)患者在位內膜中survivin與MMP-9的錶達情況併分析兩者錶達的相關性.方法:收集80例子宮內膜異位癥患者子宮內膜標本為EMs在位內膜組(EMs組),其中臨床分期Ⅰ期4例、Ⅱ期25例、Ⅲ期44例與Ⅳ期7例;增殖期47例,分泌期33例.以20例同期手術的單純子宮肌瘤患者子宮內膜作為對照組,其中增殖期內膜7例,分泌期13例.採用免疫組化二步法檢測2組標本中survivin與MMP-9的錶達;併應用IPP專業圖像分析繫統進行定量分析.結果:survivin與MMP-9均在子宮內膜胞漿中錶達.在EMs組中增殖期survivin和MMP-9及分泌期survivin錶達均高于對照組(P<0.01);其中,survivin錶達與細胞週期無關,呈持續性高錶達.EMs組不同臨床分期間survivin錶達,Ⅱ期明顯高于Ⅲ期,其餘各分期間錶達差彆無統計學意義(均P>0.05);而MMP-9在各AFS分期中錶達差彆均無統計學意義(均P>0.05).Pearson相關性分析錶明survivin與MMP-9在子宮內膜異位癥在位內膜中錶達呈正相關(r=0.262,t=2.860,P<0.05).結論:survivin與MMP-9在子宮內膜異位癥形成及進展過程中均起關鍵的作用.
목적:검측자궁내막이위증(EMs)환자재위내막중survivin여MMP-9적표체정황병분석량자표체적상관성.방법:수집80례자궁내막이위증환자자궁내막표본위EMs재위내막조(EMs조),기중림상분기Ⅰ기4례、Ⅱ기25례、Ⅲ기44례여Ⅳ기7례;증식기47례,분비기33례.이20례동기수술적단순자궁기류환자자궁내막작위대조조,기중증식기내막7례,분비기13례.채용면역조화이보법검측2조표본중survivin여MMP-9적표체;병응용IPP전업도상분석계통진행정량분석.결과:survivin여MMP-9균재자궁내막포장중표체.재EMs조중증식기survivin화MMP-9급분비기survivin표체균고우대조조(P<0.01);기중,survivin표체여세포주기무관,정지속성고표체.EMs조불동림상분기간survivin표체,Ⅱ기명현고우Ⅲ기,기여각분기간표체차별무통계학의의(균P>0.05);이MMP-9재각AFS분기중표체차별균무통계학의의(균P>0.05).Pearson상관성분석표명survivin여MMP-9재자궁내막이위증재위내막중표체정정상관(r=0.262,t=2.860,P<0.05).결론:survivin여MMP-9재자궁내막이위증형성급진전과정중균기관건적작용.
Objective:To investigate the expression of survivin and MMP-9 in the eutopic endometrium of patients with endometriosis(EMs).Methods:Eighty patients with endometriosis were selected as EMs group,four of them were in clinical stage Ⅰ,25 in stage Ⅱ,44 in stage Ⅲ and 7 in stage Ⅳ,47 in the proliferative phase and 33 in the secretory phase of the menstrual cycles.Twenty patients with hysteromyoma were selected as control group,including 7 patients in the proliferative phase and 13 in the secretory phase of the menstrual cycles.The expression levels of survivin and MMP-9 were determined by immuno-histochemical method.Image-Pro Plus 6.0(IPP),the special-purpose system for quantitative measurement of medical images,was used to analyse the results quantitatively.Results:Both survivin and MMP-9 were found positive in the plasma of the endometriosis.Both survivin and MMP-9 expression levels were higher in EMs group than those in the control group(P <0.01).Besides,survivin was over expressed with no relation to the menstrual cycle of the endometium.Survivin expression was higher in endometriosis stage Ⅱ than that of the stage Ⅲ(P > 0.05).There was no difference in survivin expression within other stages(P > 0.05).While MMP-9 expression had no difference between all the endometriosis stages(P > 0.05).There was a close relationship between survivin and MMP-9 expression levels in 80 eutopic endometfium of endometriosis(r=0.262,t=2.860,P < 0.05).Conclusion:The over expression of survivin and MMP-9 may play an important role in the pathogenesis of endometriosis.